Kidney transplantation using complement inhibitor in a patient suffering from atypical hemolytic-uremic syndrome associated with factor H antibodies: successful prevention of recurrence of the underlying disease

Atypical hemolytic-uremic syndrome (aHUS) is an extremely rare complement-mediated disease that belongs to the group of thrombotic microangiopathies (TMA). It often reoccurs after kidney transplantation (KT). Previously, KT was considered contraindicated in both children and adults with aHUS due to...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: E. I. Prokopenko, S. A. Pasov, A. V. Vatazin, A. Ya. Tsalman, T. E. Pankratenko, G. A. Generalova
Médium: Artigo
Jazyk:Russo
Vydáno: Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2020-07-01
Edice:Vestnik Transplantologii i Iskusstvennyh Organov
Témata:
atypical hemolytic-uremic syndrome
eculizumab
kidney transplantation
complement-activating conditions
On-line přístup:https://journal.transpl.ru/vtio/article/view/1194
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky